Takeda delivers resilient fy2020 results with strong margins & robust cashflow; underlying revenue growth expected to accelerate in fy2021

Osaka, japan--(business wire)--takeda pharmaceutical company limited (tokyo:4502) (nyse:tak) (“takeda”) today announced financial results for fiscal year 2020 (period ended march 31, 2021). takeda president and chief executive officer christophe weber commented: “over the course of fy2020, takeda remained resilient as we operated in new ways through the covid-19 pandemic. this is a testament to the dedication of our employees, and takeda's unwavering commitment to serving patients, our people,
TAK Ratings Summary
TAK Quant Ranking